T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (Ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules

Journal of the Formosan Medical Association

Volumn 107, Issue 10, 2008, Pages 798-805

  Chen, Ran Chou ^a,b   Lii, Jiunn Ming ^a   Chou, Chen Te ^b,c   Chang, Ting An ^a   Chen, Wei Tsung ^a   Li, Chao Shiang ^a   Tu, Hsing Yang ^a  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; Hyperplasia; Liver cell adenoma; Magnetic resonance; Ultrasmall superparamagnetic iron oxide

Indexed keywords

FERUCARBOTRAN;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; LIVER NODULE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTION;

EID: 56349102775     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(08)60193-X     Document Type: Article

References (27)

1. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 1991;178:493-7.
2. Blakeborough A, Ward J, Wilson D, et al. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology 1997;203:756-65.
3. Kang BK, Lim JH, Kim SH, et al. Preoperative depiction of hepatocellular carcinoma: ferumoxide-enhanced MR imaging versus triple-phase helical CT. Radiology 2003;226: 79-85.
4. Kim SH, Choi D, Kim SH, et al. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2005;184:1069-76.
5. Lencioni R, Della Pina C, Bruix J, et al. Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography. Dig Dis Sci 2005;50:533-7.
6. Tanimoto A, Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 2006;58:200-16.
7. Tanaka M, Nakashima O, Wada Y, et al. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 1996;24: 807-12.
8. Kawamori Y, Matsui O, Kadoya M, et al. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging. Radiology 1992;183:65-72.
9. Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000;32:205-12.
10. Reimer P, Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 2003;13:1266-76.
11. Roncalli M. Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience. Liver Transpl 2004;10:S9-15.
12. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 2004;10:S3-8.
13. Kojiro M. Histopathology of liver cancers. Best Pract Res Clin Gastroenterol 2005;19:39-62.
14. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. In: WHO Classification of Tumours, 1st edition. USA: Oxford University Press, 2001:165-6.
15. Tang Y, Yamashita Y, Arakawa A, et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 1999;172:1547-54.
16. Takeshita K, Nagashima I, Frui S, et al. Effect of superparamagnetic iron oxide-enhanced MRI of the liver with hepatocellular carcinoma and hyperpastic nodule. J Comput Assist Tomogr 2002;26:451-5.
17. Chen RC, Wang CK, Wang CS, et al. Depiction of vasculature in small hepatocellular carcinoma, and dysplastic nodules evaluated with carbon dioxide ultrasonography and angiography. Acta Radiologica 2002;43:66-70.
18. Kato H, Kanematsu M, Kondo H, et al. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity. J Magn Reson Imaging 2004;19:76-81.
19. Li CS, Chen RC, Tu HY, et al. Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography. Br J Radiol 2006;79:659-65.
20. Li CS, Chen RC, Jiunn-Ming Lii, et al. Magnetic resonance imaging appearance of well-differentiated hepatocellular carcinoma. J Comput Assist Tomogr 2006;30:597-603.
21. Zhang XH, Liang BL, Huang SQ. Correlation between SPIO-enhanced magnetic resonance imaging (MRI) and histological grading in hepatocellular carcinoma. Ai Zheng 2003;22:734-8.
22. Tarimoto A, Yuasa Y, Shinmoto H, et al. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 2002;222: 661-6.
23. Macarini L, Marini S, Murrone M, et al. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis. Radiol Med (Torino) 2004;108:92-106.
24. Stroszczynski C, Gaffke G, Gretshel S, et al. Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesion: and ROC analysis. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2003;175: 1368-75.
25. Vogl TJ, Hammerstingl R, Keck H, et al. Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium. Radiology 1995;35:258-66.
26. Pauleit D, Textor J, Bachmann R, et al. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 2003;222: 73-80.
27. Lutz AM, Willmann JK, Goepfert K, et al. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology 2005;237:520-8.